Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cardiology Reviews
  4. Volume 20, Issue 6
  5. Article
Volume 20, Issue 6
  • ISSN: 1573-403X
  • E-ISSN:
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Cardiac amyloidosis (CA) is an infiltrative disease characterized by the deposition of misfolded proteins in cardiac interstitial tissue. Interest towards studying this pathology has been growing in the last decade, as new epidemiological insights have revealed that it is not as uncommon as previously believed. Likewise, advances in non-invasive diagnostic approaches and the identification of molecules that modify its long-term progression, even in terms of mortality, have also bolstered interest in CA. Despite this global panorama, in Venezuela, limitations remain regarding the diagnosis of CA, partly associated with a lack of knowledge of the disease. Therefore, additional efforts are necessary for clinical cardiologists to hone their diagnostic skills regarding this disease, as opportune identification is an essential step for its effective management.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X305835240715092532
2024-11-01
2024-11-26

  • From This Site

    /content/journals/ccr/10.2174/011573403X305835240715092532
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/ccr/20/6/CCR-20-6-E150724231977.html?itemId=/content/journals/ccr/10.2174/011573403X305835240715092532&mimeType=html&fmt=ahah

References

  1. BuxbaumJ.N. DispenzieriA. EisenbergD.S. Amyloid nomenclature 2022: Update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee.Amyloid202229421321910.1080/13506129.2022.2147636 36420821
     [Google Scholar]
  2. AimoA. MerloM. PorcariA. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.Eur. J. Heart Fail.202224122342235110.1002/ejhf.2532 35509173
     [Google Scholar]
  3. AllegraA. MirabileG. TonacciA. GenoveseS. PioggiaG. GangemiS. Machine learning approaches in diagnosis, prognosis and treatment selection of cardiac amyloidosis.Int. J. Mol. Sci.2023246568010.3390/ijms24065680 36982754
     [Google Scholar]
  4. SuárezJ.A. PuigboJ.J. NavaJ.R. ValeroJ. GilC. Estudio anatomopatológico de 210 casos de miocardiopatías en Venezuela.Acta Medica Venezolana19681511320330
     [Google Scholar]
  5. ArriojaA. VelazcoL. AguilarR. FloresY. RamírezA. Amiloidosis cardíaca.Adv. Cardiol.2020402144145
     [Google Scholar]
  6. MutF. CarvajalI. CamillettiJ. ErriestJ. AlexandersonE. GrossmanG.B. Cardiac amyloidosis in latin america: Gaps and opportunities to increase awareness of the disease. Findings from the AMILO-LATAM research group.J. Nucl. Cardiol.20233041592160110.1007/s12350‑022‑03005‑5 35641695
     [Google Scholar]
  7. García-PaviaP. RapezziC. AdlerY. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC working group on myocardial and pericardial diseases.Eur. Heart J.202142161554156810.1093/eurheartj/ehab072 33825853
     [Google Scholar]
  8. KittlesonM.M. RubergF.L. AmbardekarA.V. Writing committee. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis.J. Am. Coll. Cardiol.202381111076112610.1016/j.jacc.2022.11.022 36697326
     [Google Scholar]
  9. BritoD. AlbrechtF.C. de ArenazaD.P. World heart federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM).Glob. Heart20231815910.5334/gh.1262 37901600
     [Google Scholar]
  10. MillerP. MaurerM.S. PoteruchaT. Socioeconomic disparities prevent equitable Tafamidis access in transthyretin cardiac amyloidosis.J. Am. Coll. Cardiol.2023818Suppl.34210.1016/S0735‑1097(23)00786‑6
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X305835240715092532
Loading
Cardiac Amyloidosis in Venezuela: A Pending Issue
Current Cardiology Reviews 20, E150724231977 (2024); https://doi.org/10.2174/011573403X305835240715092532
/content/journals/ccr/10.2174/011573403X305835240715092532
/content/journals/ccr/10.2174/011573403X305835240715092532
Loading

Data & Media loading...


  • Article Type:     Editorial
Keyword(s): Cardiac amyloidosis; cardiomyopathy; diagnosis; epidemiology; misfolded proteins; pathology; treatment; venezuela

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test